Q3 2023 Holdings
Filed 2023-11-14 | 49 holdings | $1.7B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $464.1M | 8,142,100 | 27.1% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $123.0M | 4,662,530 | 7.2% |
| Ambrx Biopharma Inc | SPONSORED ADS | 02290A102 | $114.1M | 9,923,689 | 6.7% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $77.1M | 2,150,000 | 4.5% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $76.1M | 2,000,000 | 4.4% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $57.4M | 3,850,000 | 3.3% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $55.6M | 4,504,764 | 3.2% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $53.3M | 1,056,373 | 3.1% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $49.1M | 3,570,872 | 2.9% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $47.0M | 1,225,000 | 2.7% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $46.6M | 2,621,422 | 2.7% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $43.8M | 2,879,424 | 2.6% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $33.9M | 665,000 | 2.0% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $32.8M | 1,101,904 | 1.9% |
| Immuneering Corp(IMRX) | CLASS A COM | 45254E107 | $32.3M | 4,204,364 | 1.9% |
| Pharvaris N V(PHVS) | COM | N69605108 | $28.4M | 1,361,460 | 1.7% |
| Rayzebio Inc | COM | 75525N107 | $26.2M | 1,182,263 | 1.5% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $25.6M | 3,200,000 | 1.5% |
| Karuna Therapeutics Inc | COM | 48576A100 | $23.7M | 140,000 | 1.4% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $21.8M | 1,900,000 | 1.3% |
| Erasca Inc(ERAS) | COM | 29479A108 | $21.3M | 10,813,246 | 1.2% |
| Aerovate Therapeutics Inc | COM | 008064107 | $21.2M | 1,561,696 | 1.2% |
| Marinus Pharmaceuticals Inc(MRNS*) | COM NEW | 56854Q200 | $21.1M | 2,625,000 | 1.2% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $19.5M | 850,000 | 1.1% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $16.9M | 2,946,887 | 1.0% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $16.6M | 1,216,712 | 1.0% |
| Praxis Precision Medicines I | COM | 74006W108 | $16.2M | 9,500,000 | 0.9% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $16.2M | 600,000 | 0.9% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $14.5M | 575,000 | 0.8% |
| Zentalis Pharmaceuticals Inc(ZNTL) | COM | 98943L107 | $14.0M | 700,000 | 0.8% |
| Axonics Inc(AXNX*) | COM | 05465P101 | $14.0M | 250,000 | 0.8% |
| Longboard Pharmaceuticals in | COM | 54300N103 | $13.1M | 2,353,141 | 0.8% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $11.2M | 1,762,115 | 0.7% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $10.6M | 225,000 | 0.6% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $9.8M | 1,000,000 | 0.6% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $9.2M | 450,000 | 0.5% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $6.0M | 593,043 | 0.3% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $5.4M | 325,000 | 0.3% |
| Verve Therapeutics Inc | COM | 92539P101 | $4.6M | 350,000 | 0.3% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $4.3M | 1,087,807 | 0.3% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $3.6M | 561,600 | 0.2% |
| Vigil Neuroscience Inc(VIGL) | COM | 92673K108 | $3.3M | 616,786 | 0.2% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $2.9M | 612,079 | 0.2% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $2.1M | 81,963 | 0.1% |
| Bioatla Inc(BCAB) | COM | 09077B104 | $2.0M | 1,181,115 | 0.1% |
| Neumora Therapeutics Inc.(NMRA) | COM | 640979100 | $1.3M | 92,293 | 0.1% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $913.7K | 392,167 | 0.1% |
| Harpoon Therapeutics Inc | COM NEW | 41358P205 | $217.9K | 54,060 | 0.0% |
| Orchard Therapeutics PLC | SPON ADS NEW | 68570P200 | $198.4K | 25,664 | 0.0% |